Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
CTM Biomedical General Information
CTM Biomedical develops and markets human placental connective tissue allografts and extracellular matrix structural implants designed to augment or replace damaged tissues. Their products are used in both surgical and non-surgical settings to support constructive remodeling during healing. The company has recently expanded distribution through new partnerships targeting orthopedic surgeons.[1][3]
Contact Information
Primary Industry
Implantable Medical Devices
Corporate Office
Miami, Florida
United States
United States
Drug Pipeline
CTM placental connective tissue allograft
CommercialKey Partnerships
Pivot MedTech (distribution partnership), TAG Medical (distribution partnership)[3]
CTM Biomedical Funding
No funding data available
To view CTM Biomedical's complete valuation and funding history, request access »